C

Cbeyemed

BE0774.928.644

About Cbeyemed

Cbeyemed is a private limited company (BV/SRL) based in Mons, founded in 2021. For the 2025 financial year, Cbeyemed reported a profit of €263,208. Revenue came to €490,631. Equity stands at €643,762, a solvency ratio of 83%. 3 annual accounts are available, covering 2022 to 2025.

Juridical situation
Normal situation
Company number
0774.928.644
Founding date
Founded on 01-10-2021
EUID number
BEKBOBCE.0774.928.644
Type of enterprise
Rechtspersoon
Location
Rue Des Fusillés 5 Mons 7020
Juridical form
BV — Private limited company (BV/SRL)
Activities
Signals
Profitable
Strong equity
Low risk
Good liquidity
Positive cashflow
Positive EBITDA

Financial ratios

Profit
€ 263K
Increased by 48%
Equity
€ 644K
Increased by 95%
Turnover
€ 491K
Health
Solvability > 25%
83.2%
Liquidity > 1.0
5.53
Profitability > 0%
40.9%
2025
2023
2022
Turnover
€ 491K
Gross margin
€ 370K
€ 249K
€ 196K
EBITDA
€ 369K
€ 243K
€ 195K
Profit
€ 263K
€ 178K
€ 143K
Equity
€ 644K
€ 331K
€ 153K
Solvability
83.20%
85.65%
66.28%
Debt
€ 130K
€ 55K
€ 78K
Cash
€ 515K
€ 218K
€ 116K

Frequently asked questions

Answers to the most common questions about Cbeyemed, based on official government data and the filed annual accounts.

What is the VAT number of Cbeyemed?

The VAT number of Cbeyemed is BE0774.928.644.

When was Cbeyemed established?

Cbeyemed was founded in 01-10-2021.

What is the official address of Cbeyemed?

The official address of Cbeyemed is Rue Des Fusillés 5 Mons 7020.

What is the legal form of Cbeyemed?

The juridical form of Cbeyemed is Private limited company (BV/SRL).

What is the annual revenue of Cbeyemed?

The revenue of Cbeyemed for the 2025 financial year was €490,631.

Is Cbeyemed a reliable company?

Cbeyemed is a registered Rechtspersoon with company number 0774.928.644 and can be verified through the official CBE database.

What is the credit limit of Cbeyemed?

The estimated credit limit of Cbeyemed is €585,244.

Is Cbeyemed still active?

Cbeyemed currently has the status "Normal situation" and is active.

Further reading

View all insights

Sources